Brain stem ischemia is a condition that occurs when the brain stem is deprived of sufficient blood flow and therefore cannot perform metabolism. This also causes hypoxia and the death of brain tissue, known as an ischemic stroke. Focal brain ischemia is typically caused by a blood clot or cholesterol buildup in an artery of the brain, and global brain ischemia can be caused by cardiac arrest, sickle cell anemia, or congenital heart defects. Transient brainstem ischemia is characterized by brief, reversible periods of ischemia, usually lasting under an hour. Symptoms of brain stem ischemia can be unconsciousness, vision problems, lack of motor skills, and dizziness. Treatment for brain stem ischemia include regulating the blood pressure into the brain as well as taking preventative measures against seizures, as they are likely to occur following a brain ischemia. Because the brain stem is a critical component in basic functions, blood loss to this area is very detrimental, and while transient episodes are reversible, they could lead to instances of ischemia that lead to permanent brain damage and even death.
Transient Brainstem Ischemia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Transient Brainstem Ischemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 134 products for the study of Transient Brainstem Ischemia that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Transient Brainstem Ischemia is also known as Brainstem Transient Ischemic Attack.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.